SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients
NCT00940888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1701
Last updated 2019-02-04
Summary
The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
Conditions
- Tachyarrhythmias
- Sudden Cardiac Death
- Heart Failure
Interventions
- DEVICE
-
SJ4 connector and RV high voltage SJ4 lead
Standard of care implantation of SJ4 device system
Sponsors & Collaborators
-
Abbott Medical Devices
lead INDUSTRY
Principal Investigators
-
Bruce Wilkoff, MD · The Clevleland Clinic Foundation
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Multipolar CRT-d and Diabetes
NCT03095196 ·Status: COMPLETED
-
Study of the Wearable Defibrillator in Heart-Failure Patients
NCT01326624 ·Status: COMPLETED
-
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
NCT00203333 ·Status: COMPLETED
-
Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator
NCT04292405 ·Status: TERMINATED
-
St.Jude Medical Cardiac Lead Assessment Study
NCT01507987 ·Status: COMPLETED
-
SJM MRI Diagnostic Imaging Registry (IDE)
NCT02807948 ·Status: COMPLETED ·Phase: NA
-
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
NCT01097330 ·Status: TERMINATED ·Phase: PHASE3
-
Multisite Pacing With a Quadripolar Lead
NCT00964938 ·Status: COMPLETED ·Phase: PHASE4
-
Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
NCT02548455 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous ICD Therapy Combined With VT Ablation for the Secondary Prevention of Sudden Cardiac Death
NCT03622307 ·Status: UNKNOWN ·Phase: NA
-
Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.
NCT07157449 ·Status: NOT_YET_RECRUITING
-
Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study
NCT00187239 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
NCT05992623 ·Status: COMPLETED ·Phase: NA
-
Coronary Artery Bypass Graft (CABG) Patch Trial
NCT00000540 ·Status: COMPLETED ·Phase: PHASE3
-
The Jewel IDE Study
NCT05201495 ·Status: COMPLETED ·Phase: NA
-
STandardized Ultra-conservative Or Physician-directed ICD Programming for Continuous Flow LVAD Support
NCT04264182 ·Status: TERMINATED ·Phase: NA
-
Implantable Cardioverter Defibrillators - Improving Risk Stratification
NCT01944514 ·Status: COMPLETED
-
Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System
NCT00399217 ·Status: COMPLETED
-
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
NCT00990665 ·Status: COMPLETED ·Phase: NA
-
Antiarrhythmics Versus Implantable Defibrillators (AVID)
NCT00000531 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms
NCT00916435 ·Status: COMPLETED
-
Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study
NCT01227785 ·Status: COMPLETED
-
Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy
NCT00947310 ·Status: COMPLETED ·Phase: NA
-
Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
NCT00180297 ·Status: COMPLETED ·Phase: NA
-
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
NCT00000609 ·Status: COMPLETED ·Phase: PHASE3